or
Light stint implant device for treatment of long term viral infection



Bookmark and Share
PDF+Word+Text
Download of US
Patent 6409719
Bulk Download
of 50+ Related
Patent PDFs
$39.95
Document Number
US Patent 6409719
Issued Date
June 25, 2002
Link
Inventors
Manning; Don A. (Monroeville, AL)
Map
Abstract
A light stint implant device adapted to be surgically implanted in a major blood vessel for assisting in the treatment of long term viral infection, alone or in combination with anti-viral drugs, is disclosed. The implant device is programmed for set periods of illumination and set periods of dormancy through a remote power supply and timing device accessible through a sub-dermal implant adapted to be surgically placed in a location under the skin. The device, after being implanted within such blood vessel will eliminate viruses located within the blood through exposure to light given off by the light stint implant device during the periods of illumination.
Drawing
Light stint implant device for treatment of long term viral infection - US Patent 6409719 Drawing
Drawing from US Patent 6409719
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
4
Comments:
no comments yet
Owner
Published
June 25, 2002
Application Number
09/663,786
Filed
September 18, 2000
US Classification
606/14   604/21 604/288.01 604/288.02 606/41 606/42 606/7 607/100 607/88 607/92 607/94 607/98
Int'l Classification
A61L   2/00   (20060101)   A61K   41/00   (20060101)   A61N   5/06   (20060101)  
Assistant Examiner
Attorney/Law Firm
USPTO Field of Search
606/7   606/13   606/14   606/41   606/42   607/92   607/93   607/94   607/100   604/4.01   604/6.03   604/6.08   604/21   604/43   604/288.01   604/288.02   604/891.1  
Related Patents
7465313 - Red light implant for treating degenerative disc disease - Owned by Depuy Spine, Inc. (Raynham, MA)

Red light-emitting implants for treating degenerative disc disease.

7544204 - Control of halitosis-generating and other microorganisms in the non-dental upper respiratory tract - Owned by Valam Corporation (New York, NY)

Disclosed are safe, simple and effective broad-spectrum treatments for halitosis and other microbial infections of the nondental upper respiratory tract useful to treat bacterial and other microorganism species, including anaerobic bacteria. Electromagnetic radiative energy including visible, and optionally, thermal, RF and/or microwave wavelengths, is topically applied to internal surfaces of the upper respiratory tract to destroy or incapacitate superficial microorganisms without the use of antibiotics. One useful apparatus is a handheld energy applicator having a light output head suitable for treating the back of the tongue and the tonsils and which may be interchangeably provided with extensions to reach the sinuses. The energy applicator can be supported and guided by a mounting device held between the subject's teeth, if desired. Useful embodiments of the invention include preparative treatment of the target surfaces with a photosensitizing agent such as an oxidizing agent or a complementary stain. Optionally a pre-treament procedure may be employed to remove detritus and microfloral overgrowths that may mask more deeply resident target microorganisms. Novel treatments include treatment of halitosis by destruction of bacterial species associated with halitosis, such as Atopobium parvulum, by application of non-ionizing radiative energy to the tonsils and the back of the tongue. Another embodiment comprises a candy bar incorporating a halitosis treatment lamp disposed within the candy.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us